← Leaderboards
Mark Yarmarkovich
New York University School Of Medicine
$1,801,790
Attributed
$1,801,790
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$1,801,790 · 2
By mechanism
DP2$1,525,500 · 1
OT2$276,290 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Els Fieremans$7,713,461
- Anthony Tao$158,420
- Dmitry S Novikov$5,695,763
- Erika Pratt Raven$869,189
- Iannis Aifantis$31,581,069
Others in their field
Other Rising Stars on “Next Generation”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Mari Ostendorf · University Of Washington$51,931,230
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Jonathan H Elias · Association Of Universities For Research In Astronomy, Inc.$16,042,279
Research focus
Next GenerationPre-Clinical ModelGenerationsMutationT Cell TherapyTumorChimeric Antigen Receptor T CellsEngineeringImmune EvasionMalignant NeoplasmsReceptorSolid NeoplasmCancer CellCancer PatientAntigensChimeric Antigen ReceptorClinical TrialsComplexHigh RiskImmuneImmunotherapyMalignant Childhood NeoplasmAwardBrain Neoplasms
Grant awards (4)
Next Generation T cell therapies for childhood cancers (NexTGen)$97,535
OT2 · FY2025 · CA · contact PI
Expanding CAR T cell applications through high-throughput forward- and reverse immune engineering$1,525,500
DP2 · FY2024 · CA · contact PI
Next Generation T cell therapies for childhood cancers (NexTGen)$76,492
OT2 · FY2024 · CA · contact PI
Next Generation T cell therapies for childhood cancers (NexTGen)$102,263
OT2 · FY2023 · CA · contact PI